Warning Claims Not Barred, but Metoclopramide Suit Tossed

A woman alleging she developed the movement disorder tardive dyskinesia from the generic heartburn drug metoclopramide can’t sue the manufacturers (Woods v. Wyeth, LLC, 2016 BL 136987, N.D. Ala., 13-543, 4/29/16).

Linda Woods’s claims that generic drugmakers Barr Laboratories, Pliva Inc., Ranbaxy Pharmaceuticals Inc. and Teva Pharmaceutical USA used outdated warnings aren’t barred by federal drug labeling law, the U.S. District Court for the Northern District of Alabama said April 29.

But the court said the suit fails because Woods can’t link her physicians’ prescribing decisions to the generic drug labels.

Woods’s physician prescribed Reglan, the branded ...